Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,285.9
3.9 (0.12%)

 

  • STI Straits Times Index
    3,285.9
    3.9 (0.12%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,542.7
    -12.7 (-0.81%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,207.1
    -176.2 (-0.72%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,541.7
    20.4 (0.58%)
    Index delayed 15 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 627.9M
  • Value: 789.1M
  • Rise: 113
  • Fall: 178
  • Unch: 470

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.084+0.001
Shen Yao0.003-
Jiutian Chemical0.083+0.001
RH PetroGas0.192+0.002
Singtel2.490+0.040
DISA0.009-
ThaiBev0.640-0.010
Vividthree0.062-0.001
Kep Infra Tr0.550+0.005
Mapletree Com Tr1.840+0.010

World Indices

World Indices
Name Last Change
Nasdaq 14,893.8 +86.9
HSI 24,207.4 -175.9
HSCEI 8,460.4 -94.4
Jakarta 6,638.4 -55.0
Nikkei 225 28,333.5 +209.2
SSE Comp 3,541.7 +20.4
Shanghai A 3,711.5 +21.5
Shanghai B 287.2 +0.3
KOSPI 2,890.1 -31.8

Nikkei 225 updated at end-of-day. Other Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Medtecs Intl MEDTECS INTERNATIONAL CORP LTD
Quotes 10 Minutes Delayed. Updated at 17 Jan 2022 15:49
Last (SGD): 0.325 Change: -0.010 High: 0.335 Remarks: -
Change (%): -2.99 Low: 0.320
Open 0.335 Yesterday's Close 0.335
Buy Price 0.325 Sell Price 0.330
Buy Volume ('000) 62.2 Sell Volume ('000) 274.8
Cumulative Volume ('000) 1,375.0 Cumulative Value 449,256

Company Background

The Group's business started in 1989 with the incorporation of Clement Textile & International Corporation in Philippines in 1989. Medtecs is an integrated healthcare product and services provider in Asia Pacific, and a manufacturer and distributor of medical consumables for the healthcare industry. Started in the Philippines in 1989, the Group has established its presence in the United States, Europe and the Asia Pacific region. Today, the Group has offices in Singapore, Hong Kong, Taiwan, the Philippines, Cambodia and China.The Group is an original product manufacturer (OPM) of a wide range of medical consumables for large multinational healthcare distributors, pharmaceutical companies and hospital groups in the United States and Europe. Major product groups manufactured by the Group include linen, hospital apparel, hospital apparel and bandages. The Group’s OPM is supported by 10 manufacturing facilities located in the Philippines (4), China (4) and one each in Cambodia and Taiwan.The Group also acts as agent to distribute other branded medical devices in Asia Paci8fic, including medical supplies and equipment such as wheel chairs, syringes, gauzes, digital thermometers, nebulizers, blood pressure monitors and others.The Group’s Taiwan Depository Receipts (TDR) was listed on the Taiwan Stock Exchange on 13 December 2002.The Company is an investment holding company incorporated in Bermuda on 26 November 1997.

Click to show Stock Prices chart

Key Statistics

EPS (SGD) a 0.31869 Trailing EPS (SGD) b 0.26644 NAV (SGD) c 0.4594
PE a 1.020 Trailing PE d 1.220 Price / NAV c 0.7074
Dividend Yield (%) e 20.761 Cash In Hand (SGD) f 0.1504 Issued & Paid-up Shares g 546,411,000
Piotroski F Score 8 Market Cap (M) 177.584 Free Float (%) 99.4
Return on Equity (ROE) (%) h 57.995 Revenue Growth (%) TTM i 52.006
Net Earnings Growth (%) j 163.617 Net Debt/Equity k Net Cash
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Manufacturing - Medical Specialties
Category Classification Medical & Biotechnology
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted based on Profit Attributable To Shareholders.
  2. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  3. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  4. Based on latest Full Year results announcement, adjusted for the current number of shares.
  5. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  6. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  7. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 24 Aug 2021. Please click here for more information.
  8. Calculated based on Net Earnings / (Shareholders' Equity - Other Share Capital)
  9. Calculated based on (Current Year Revenue - Last Year Revenue) / Last Year Revenue
  10. Calculated based on (Current Year Earnings - Last Year Earnings) / Last Year Earnings
  11. Calculated based on (Long Term Debt + Short Term Debt - Cash and Short Term Investments)/(Shareholders' Equity - Other Share Capital)

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.040
-10.96 %
10 Days --0.025
-7.14 %
20 Days --0.020
-5.80 %
Medium Term Return 3 Months --0.065
-16.67 %
6 Months --0.495
-60.37 %
1 Year 0.056-0.795
-65.98 %
Long Term Return 2 Years 0.067+0.275
+684.00 %
3 Years 0.067+0.297
+1300.00 %
5 Years 0.067+0.277
+716.67 %
Annualised Return Annualised --
+52.20 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Medtecs Intl SGX 177.584 1.020 1.220 0.7074 20.761
Industry Medical & Biotechnology SGX 1,039.512 19.207 15.801 1.4521 1.889
Medical Specialties SGX 1,080.235 2.297 3.137 2.8204 24.057
Index FTSE ST Catalist Index SGX 61.766 26.798 21.260 1.4043 2.046
Local Peer Top Glove SGX 6,005.329 2.359 3.291 3.3069 25.298
Local Peer UGHealthcare SGX 187.148 1.576 1.576 0.9817 1.683
Local Peer Yunnan Energy SGX 46.549 - - 1.4359 -
Local Peer Biolidics SGX 45.392 - - 8.5930 -
Local Peer Annica SGX 16.675 - - 10.0000 -
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 234,379.750 36.765 27.365 6.0548 0.149
Global Peer ABBOTT LABORATORIES NYSE 226,624.046 50.665 31.423 6.5837 1.196
Global Peer DANAHER CORP NYSE 209,592.580 59.713 36.629 5.2159 0.244
Global Peer MEDTRONIC PLC NYSE 145,951.988 40.475 31.021 2.8073 2.231
Global Peer INTUITIVE SURGICAL INC NASDAQ 109,854.563 - - - -
Global Peer STRYKER CORP NYSE 100,613.680 62.923 52.955 7.0965 0.880
Global Peer BECTON DICKINSON & CO NYSE 74,857.993 37.392 37.392 3.1619 1.277
Global Peer EDWARDS LIFESCIENCES CORP NYSE 73,833.739 89.669 49.979 13.3243 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 63,925.051 - 61.348 3.8832 -
Global Peer IDEXX LABORATORIES INC NASDAQ 44,885.492 77.153 59.305 59.4702 -
Other Global Peers AGILENT TECHNOLOGIES INC (NYSE), DEXCOM INC (NASDAQ), BAXTER INTERNATIONAL INC (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), ALCON AG (NYSE), RESMED INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), STERIS PLC (NYSE), PERKINELMER INC (NYSE), WATERS CORP (NYSE), COOPER COS INC (NYSE), BIO RAD LABORATORIES INC (NYSE), HOLOGIC INC (NASDAQ), INSULET CORPORATION (NASDAQ), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), TELEFLEX INC (NYSE), ABIOMED INC (NASDAQ), MASIMO CORPORATION (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), DENTSPLY SIRONA INC (NASDAQ), QIAGEN NV (NYSE), BRUKER CORPORATION (NASDAQ), COCHLEAR LTD (ASX), PENUMBRA INC (NYSE), TANDEM DIABETES CARE INC (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), GLOBUS MED INC (NYSE), NOVOCURE LTD (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), MICROPORT SCIENTIFIC CORPORATION (HKEx), SHANGHAI MICROPORT MEDBOT (GROUP) C (HKEx), SOTERA HEALTH CO (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), SHANDONG WEIGAO GROUP MEDICAL (HKEx), EBOS GROUP (ASX), QUIDEL CORP (NASDAQ), ANGELALIGN TECHNOLOGY INC (HKEx), ICU MEDICAL INC (NASDAQ), HARTA (Bursa), STEVANATO GROUP S.P.A. (NYSE), ORTHO CLINICAL DIAGNOSTICS HLD PLC (NASDAQ), LIVANOVA PLC (NASDAQ), TOPGLOV (Bursa), NEOGEN CORP (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), CONMED CORP (NYSE), INARI MEDICAL INC (NASDAQ), INMODE LTD (NASDAQ), STAAR SURGICAL CO (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), NEVRO CORP (NYSE), ATRICURE INC (NASDAQ), NUVASIVE INC (NASDAQ), HAEMONETICS CORP (NYSE), GLAUKOS CORPORATION (NYSE), AXONICS INC (NASDAQ), THE BEAUTY HEALTH COMPANY (NASDAQ), CAREDX INC (NASDAQ), LIFETECH SCIENTIFIC CORP (HKEx), LANTHEUS HOLDINGS INC (NASDAQ), CYTEK BIOSCIENCES INC (NASDAQ), OUTSET MEDICAL INC (NASDAQ), VERICEL CORP (NASDAQ), HESKA CORP (NASDAQ), VENUS MEDTECH (HANGZHOU) INC (HKEx), AVANOS MEDICAL INC (NYSE), MESA LABORATORIES INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), CUE HEALTH INC (NASDAQ), KANGJI MEDICAL HLDGS LTD (HKEx), BIOLIFE SOLUTIONS INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), PARAGON 28 INC (NYSE), ATRION CORP (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), NANOSONICS LIMITED (ASX), BUTTERFLY NETWORK INC (NYSE), VAREX IMAGING CORPORATION (NASDAQ), MICROPORT CARDIOFLOW MEDTECH CORP (HKEx), BIOVENTUS INC (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY (HKEx), PULMONX CORPORATION (NASDAQ), CHINA ISOTOPE & RADIATION CORP (HKEx), CERUS CORP (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), PEIJIA MEDICAL LIMITED (HKEx), AK MEDICAL HLDGS LTD (HKEx), PROCEPT BIOROBOTICS CORP (NASDAQ), ANGIODYNAMICS INC (NASDAQ), SUPERMX (Bursa), VIEWRAY INC (NASDAQ), VICARIOUS SURGICAL INC (NYSE), AIRSCULPT TECHNOLOGIES INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), SI BONE INC (NASDAQ), CRYOLIFE INC (NYSE), SIGHT SCIENCES INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), INOGEN INC (NASDAQ), BEIJING CHUNLIZHENGDA MED INST CO (HKEx), INTERCURE LTD (NASDAQ), CUTERA INC (NASDAQ), SURMODICS INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), MODERN DENTAL GROUP LIMITED (HKEx), SISRAM MEDICAL LTD (HKEx), NYXOAH SA (NASDAQ), BRONCUS HOLDING CORPORATION (HKEx), NANO-X IMAGING LTD (NASDAQ), INCANNEX HEALTHCARE LTD (ASX), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), 908 DEVICES INC (NASDAQ), IRADIMED CORP (NASDAQ), SEMLER SCIENTIFIC INC (NASDAQ), SHANGHAI HEARTCARE MEDICAL TECHNOLO (HKEx), SEASPINE HOLDINGS CORP (NASDAQ), METRICS INCOME OPPORTUNITIES TRUST (ASX), TRANSMEDICS GROUP INC (NASDAQ), VAPOTHERM INC (NYSE), DERMTECH INC (NASDAQ), STEREOTAXIS INC (NYSE American), LUMIRADX LTD (NASDAQ), ACOTEC SCIENTIFIC HLDGS LTD (HKEx), APYX MEDICAL CORPORATION (NASDAQ), SHANGHAI KINDLY MED INSTRS CO LTD (HKEx), ACCURAY INCORPORATED (NASDAQ), AXOGEN INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), YESTAR HEALTHCARE HOLDINGS CO LTD (HKEx), UTAH MEDICAL PRODUCTS (NASDAQ), ZYNEX INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), AVITA MEDICAL INC (NASDAQ), LUCIRA HEALTH INC (NASDAQ), NEUROPACE INC (NASDAQ), AROA BIOSURGERY LTD (ASX), MEDICAL DEVELOPMENT INTL (ASX), FLUIDIGM CORP DEL (NASDAQ), SUZHOU BASECARE MEDICAL CORP LTD (HKEx), SHANGHAI CONANT OPTICAL CO LTD (HKEx), APOLLO ENDOSURGERY INC (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), IMPEDIMED LIMITED (ASX), EARGO INC (NASDAQ), SONENDO INC (NYSE), QUOTIENT LTD (NASDAQ), PROFOUND MED CORP (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), CVRX INC (NASDAQ), PW MEDTECH GROUP LIMITED (HKEx), ATOSSA THERAPEUTICS INC (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), CORMEDIX INC (NASDAQ), SIENTRA INC (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), ONCOCYTE CORP (NASDAQ), TELA BIO INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), PAVMED INC (NASDAQ), MINERVA SURGICAL INC (NASDAQ), CLARITY PHARMACEUTICALS LTD (ASX), LUCID DIAGNOSTICS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), INTRICOM CORP (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), CYTOSORBENTS CORP (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), CONFORMIS INC (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), SOMNOMED LIMITED (ASX), CYCLOPHARM LIMITED (ASX), SURGALIGN HOLDINGS INC (NASDAQ), LUMOS DIAGNOSTICS HOLDINGS LIMITED (ASX), ENLIVEX THERAPEUTICS LTD (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), FONAR CORP (NASDAQ), NEURONETICS INC (NASDAQ), ELECTROMED INC (NYSE American), ATOMO DIAGNOSTICS LIMITED (ASX), ICECURE MEDICAL LTD (NASDAQ), CRYO-CELL INTERNATIONAL INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), RGTBHD (Bursa), INVACARE CORP (NYSE), IRIDEX CORP (NASDAQ), MICRO-X LTD (ASX), ALPHA PRO TECH (NYSE American), SDI LTD (ASX), VOLITIONRX LIMITED (NYSE American), VINCENT MEDICAL HOLDINGS LTD (HKEx), CLEANSPACE HOLDINGS LTD (ASX), REWALK ROBOTICS LTD (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), OPTISCAN IMAGING (ASX), KELFRED HOLDINGS LTD (HKEx), BIOSIG TECHNOLOGIES INC (NASDAQ), IMMUCELL CORP (NASDAQ), LENSAR INC (NASDAQ), INTEGRITY APPLICATIONS INCORPORATIO (NASDAQ), TITAN MEDICAL INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), CHECK-CAP LTD (NASDAQ), BIOLASE INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), RESONANCE HEALTH LTD (ASX), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), ENVVENO MED CORP (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), DIMERIX LTD (ASX), PREDICTIVE ONCOLOGY INC (NASDAQ), BIOMERICA INC (NASDAQ), ELECTROCORE INC (NASDAQ), NEPHROS INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), BLUEJAY DIAGNOSTICS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), NUTRIBAND INC (NASDAQ), CARDIEX LTD (ASX), COMPUMEDICS (ASX), MEDAVAIL HOLDINGS INC (NASDAQ), DAXOR CORP (NYSE American), ROCKWELL MEDICAL INC (NASDAQ), CELSION CORPORATION (NASDAQ), YUNNAN ENERGY INTL CO LTD (HKEx), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), KEWAUNEE SCIENTIFIC CORP (NASDAQ), ADVENTA (Bursa), NOVA EYE MEDICAL LIMITED (ASX), SOLENO THERAPEUTICS INC (NASDAQ), NEUROMETRIX INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), NEOVASC INC (NASDAQ), AVINGER INC (NASDAQ), APPLIED UV INC (NASDAQ), RESPIRI LTD (ASX), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), TIVIC HEALTH SYSTEMS INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), LBT INNOVATIONS LTD (ASX), NANOVIBRONIX INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX), PETVIVO HLDGS INC (NASDAQ), HEARTBEAM INC (NASDAQ), RESHAPE LIFESCIENCES INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), INSPIRA TECH OXY BHN LTD (NASDAQ), INSPIREMD INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), TRUSCREEN GROUP LTD (ASX), ADHERIUM LIMITED (ASX), TENAX THERAPEUTICS INC (NASDAQ), CYANOTECH CORP (NASDAQ), LKL (Bursa), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), DYNATRONICS CORP (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), METALICITY LIMITED (ASX), LIFE HEALTHCARE GROUP LTD (HKEx), OVENTUS MEDICAL LTD (ASX), USCOM LTD (ASX), SINTX TECHNOLOGIES INC (NASDAQ), HUAKANG BIOMEDICAL HLDGS CO LTD (HKEx), VIVEVE MEDICAL INC (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), THERMOGENESIS HOLDINGS INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), NUWELLIS INC (NASDAQ), STAR EQUITY HOLDINGS INC (NASDAQ), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), RA MEDICAL SYSTEMS INC (NYSE American), ANALYTICA (ASX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

More Information Available

More information is available to our subscribers, including:

  • Consensus Estimates
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.